Prognostic Value of Baseline High-Uptake PSMA Tumor Volume Fraction in Metastatic Castration-Resistant Prostate Cancer Patients Treated with [(177)Lu]Lu-PSMA Radioligand Therapy.
Overview & Synopsis
Open access biomedical research article published in Cancers (Basel).
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Prognostic Value of Baseline High-Uptake PSMA Tumor Volume Fraction in Metastatic Castration-Resistant Prostate Cancer Patients Treated with [(177)Lu]Lu-PSMA Radioligand Therapy. |
|---|---|
| Author / Organization | Cuzzocrea M, Pecoraro G, Iacovitti CM, Martinello C, Treglia G, Gillessen S, Pedrani M, Paone G |
| Subject & Discipline | Cancers (Basel) |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-259283 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |